ChiCTR-TRC-14004839
尚未开始
/
/
/
2014-09-21
/
/
近視
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性隨機對照臨床試驗
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性隨機對照臨床試驗
青光眼藥物治療用於控制近視LASIK術後回退的功效及安全性
随机平行对照
Ⅳ期
Random
/
Department of Ophthalmology Visual Sciences, The Chinese University of Hong Kong
/
87
/
1990-01-01
1990-01-01
/
1. Patients with myopia or myopic astigmatism aged 21 years or more; 2. Anisometropia < 1 diopter.;
登录查看1. Patients aged < 21 years; 2. Patients in which the target refraction is not emmetropia; 3. Patients with ocular inflammation, diabetes mellitus, connective tissue disorders; 4. Patients who have used retinoid acid or equivalent in the past 6 months; 5. Patients with known cardiac disease or bronchial asthma.;
登录查看Department of Ophthalmology Visual Sciences, the Chinese University of Hong Kong
/
diabetes 埃诺格鲁肽 SLIMMER
医药笔记2025-06-22
遗传性血管性水肿 III期 BD项目
美柏资本2025-06-22
ADA GIPR PCSK9
信达生物2025-06-22
diabetes 埃诺格鲁肽 内分泌学
先为达生物2025-06-22
PDL1 三阴性乳腺癌 atezolizumab
BioArtMED2025-06-21
EGFR 结直肠癌 JMT101
石药集团2025-06-21
糖尿病 GLP-1/GIP
恒瑞医药2025-06-21
肥胖 Wegovy
一度医药2025-06-21